ACQUISITION, Part I (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	6 Months Ended
	Jun. 25, 2012	Jun. 30, 2012
ACQUISITION [Abstract]
Convertible Price Per Share for Outstanding eBio Shares (in dollars per share)	$ 38.18
Business Acquisition, Cost of Acquired Entity, Purchase Price	$ 315,106
Business Acquisition, Cost of Acquired Entity, Accelerated Vesting of eBioscience stock options	8,265
Acquisition Consideration	306,841
Debt Instrument, 4.00% Interest Rate, Stated Percentage	4.00%
Components of Cash Paid for the Acquisition [Abstract]
Acquisition Consideration	306,841
Business Acquisition, Cost of Acquired Entity, Acceleration of Stock Options	8,265
Total purchase price	315,106
Determination of Consideration Transferred to Acquisition Date Fair Values of Assets Acquired and Liabilities Assumed [Abstract]
Cash and Cash Equivalents Acquired	7,095
Accounts Receivable, Net Acquired	9,488
Inventories, Net Acquired	52,060
Prepaid Expenses and Other Assets Acquired	7,844
Plant, Property and Equipment Net Acquired	5,969
Intangible Assets Net Acquired	159,755
Other Noncurrent Assets Acquired	1,769
Identifiable Assets Acquired	243,980
Accounts Payable and Accrued Liabilities Acquired	(18,681)
Deferred Tax Liabilities, Net Acquired	(55,542)
Other Noncurrent Liabilities Acquired	(3,241)
Identifiable Liabilities Acquired	(77,464)
Goodwill	140,325
Business Acquisition, Cost of Acquired Entity, Purchase Price	306,841
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory	$ 30,367	$ 30,367